Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513851
Status:
COMPLETED
Last Update Posted:
2011-09-27
First Post:
2007-08-07
Brief Title:
Phase 1 Study of OSI-930 in Cancer Patients
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumors |